Dr Reddy’s signs MoU with Purdue University for drug research and development

29 Jul 2015 Evaluate

In order to strengthen pharmaceutical research and development, Dr Reddy’s Laboratories (DRL) has signed a memorandum of Understanding (MoU) with Purdue University. This MoU will  forge a strong strategic partnership in a range of research areas and novel technologies in the field of pharmaceutical processes and product development.

The collaboration will include student engagement and faculty exchanges and may include a site at Purdue Research Park.

Dr Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1240.00 4.85 (0.39%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×